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Abstract 
Aim: Inflammatory markers such as serum C-reactive protein (CRP) are used as routine markers to 
detect anastomotic leakage following colorectal surgery. However, CRP is characterized by a 
relatively low predictive value, emphasizing the need for the development of novel diagnostic 
approaches. Volatile organic compounds (VOCs) are gaseous metabolic products deriving from all 
conceivable bodily excrements and reflect (alterations in) the patient’s physical status. Therefore, 
VOCs are increasingly considered as potential non-invasive diagnostic biomarkers. The aim of this 
study was to assess the diagnostic accuracy of urinary VOCs for colorectal anastomotic leakage.  
Methods: In this explorative multicentre study, urinary VOC profiles of 22 patients with confirmed 
anastomotic leakage and 27 uneventful control patients following colorectal surgery were analysed by 
field asymmetric ion mobility spectrometry (FAIMS).  
Results: Urinary VOCs of patients with anastomotic leakage could be distinguished from control 
patients with high accuracy; AUC: 0.91 (95% CI: 0.81-1.00, p<0.001), sensitivity: 86% and specificity: 
93%. Serum CRP was significantly increased in patients with a confirmed anastomotic leak but with 
lower diagnostic accuracy compared to VOC analysis (AUC: 0.82, 95% CI: 0.68 – 0.95, p<0.001). 
Combining VOCs and CRP did not result in a significant improvement of its diagnostic performance 
compared to VOCs alone. 
Conclusion: Analysis by FAIMS allowed for discrimination between urinary VOC profiles of patients 
with a confirmed anastomotic leak and control patients following colorectal surgery. A superior 
accuracy compared to CRP and apparently high specificity was observed, underlining its potential as a 
non-invasive biomarker for the detection of colorectal anastomotic leakage. 
 
Keywords: Colorectal surgery, Anastomotic leakage, Volatile organic compounds, Field asymmetric 
ion mobility spectrometry 
 
What does this paper add to the literature 
This study is the first to our knowledge to investigate urinary VOCs in the detection of colorectal 
anastomotic leakage. A superior accuracy compared to serum CRP was observed, underlining its 
potential as a novel non-invasive biomarker for the detection of colorectal anastomotic leakage. 
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Introduction  
Major morbidity and mortality following colorectal surgery is caused almost entirely by postoperative 
anastomotic leakage. Studies show that anastomotic leakage has a negative impact on short-term 
outcomes with an increased risk of postoperative mortality (1), the need for reoperation frequently 
accompanied by a permanent stoma (2), hospital length of stay (3) and hospital cost (4). In addition, 
some data have shown that anastomotic leakage might influence long-term oncological outcomes (5-
8). A recent meta-analysis concluded that leakage is associated with increased local recurrence and 
subsequent reduced long-term survival (9). Timely detection of anastomotic leakage could enable 
early intervention, possibly leading to better outcome and timely start of adjuvant treatment.  
 
In current practice, anastomotic leakage is diagnosed based on a combination of clinical, biochemical 
and radiological findings. Before radiological imaging, inflammatory markers such as C-reactive 
protein (CRP) are used as predictive markers for the diagnosis and follow-up of anastomotic leakage. 
Even though studies document positive results, CRP is characterized by relatively low positive 
predictive value. A wide range in cut-off points is also seen (10-12). This emphasizes the need for the 
development of novel diagnostic approaches, preferably non-invasive, with a high degree of accuracy 
for diagnosing anastomotic leakage following colorectal surgery.  
 
Volatile organic compounds (VOCs) are produced by colonic fermentation as a result of an interaction 
between colonocyte cells, mucosal integrity and the colonic microbiome (13). Analysis of VOCs in 
faeces results in a reflection of the gut microbiota composition. Microbiota composition is subjected to 
infectious processes leading to bacterial dysbiosis (14).  VOCs also originate from pathophysiological 
processes such as oxidative stress and inflammation. These molecules are able to diffuse into the 
circulation and are excreted by the kidneys. As a result, urinary VOCs have been shown to be 
accurate biomarkers for the detection of gastrointestinal diseases (15-17) and pancreatic anastomotic 
leakage (18). Therefore, biomarkers that emerge from all conceivable bodily excrements are thought 
to be the future of non-invasive diagnostics (19). 
 
The aim of this study was to determine whether urinary VOC analysis could discriminate between 
patients with anastomotic leakage and uneventful control patients following major colorectal surgery. 
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Methods 
Study design and participants 
This project was designed as a prospective multicentre cross-sectional study between March 2015 
and December 2016 and was reported according to the STROBE guidelines (20). Eligible participants 
were planned to undergo open or minimally invasive colorectal surgery, consisting of hemicolectomy, 
low anterior resection, sigmoid resection, subtotal colectomy, resection of small intestine or restoration 
of intestinal continuity via closure of an ostomy. Surgery was performed in five participating centres in 
the Netherlands and under standardized antibiotic prophylaxis (cefuroxime and metronidazole). All 
patients were aged 18-90 years and had an American Society of Anaesthesiologists (ASA) physical 
status of three or lower.  
 
Definitions and inclusion 
A single centre ten month period between March 2015 and December 2015 was predetermined to 
include control patients without anastomotic leakage. This control group consisted of a prospective 
cohort of consecutive patients scheduled for colorectal surgery. Urine samples were collected on 
postoperative day three. Subsequently a multicentre twelve month time period (between January 2016 
and December 2016) was started to identify all patients eligible for inclusion and with a high suspicion 
of anastomotic leakage, by a combination of clinical deterioration, biochemical findings and/or 
radiological imaging. Urine samples were collected when leakage was clinically suspected. Inclusion 
followed after confirmation of the leak by either CT imaging or surgical exploration. All samples were 
collected before initiation of treatment. 
Anastomotic leakage was defined as a defect of the intestinal wall at the anastomotic site. Severity 
was graded, according to the International Study Group of Rectal Cancer (ISREC), based on required 
treatment (21). All other postoperative complications were registered. In addition, white blood cell 
count (WBC) and C-reactive protein (CRP) were extracted from the patients charts on the day urine 
samples were collected. Patient, surgery and pathology characteristics were prospectively registered. 
 
Sample collection 
Urinary samples were collected in standard 4.5ml containers (Cryopure®). Collection took place on 
postoperative day three for control patients, which was chosen based on the median time of urinary 
catheter removal and early discharge of uneventful patients. For patients with anastomotic leakage 
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time of collection was related to timing of its clinical suspicion. All samples were obtained from urinary 
catheters. Subsequently, samples were frozen at -80° C within two hours of collection for 
simultaneous batch analysis.  
 
Field asymmetric ion mobility spectrometry of urinary gas 
Urinary gas analysis was performed using a commercially available field asymmetric ion mobility 
spectrometry (FAIMS) unit (Lonestar® with ATLAS sampling system, Owlstone, UK). This unit 
separates VOCs based on their mobility in high electric fields. It uses a radiation source (Ni-63) to 
ionize VOCs before they pass between parallel plates. Onto these plates an asynchronous high 
electric field is applied (22). This results in ions either being attracted/repelled by one of the plates or 
having no effect. If an ion touches a plate, it loses its charge and only ions that exit the plates with 
their charge are detected. To remove the effect of this ion drift, a compensation voltage is added and 
therefore, by scanning through different compensation voltages (in this case from +6V to -6V), it is 
possible to scan through a range of mobilities. As mobility can be a function of electric field strength, 
the magnitude of the electric fields is also scanned through a range of values (typically 51 steps from 0 
to 100 on the instrument, with each step having a compensation voltage sweep). Each urine sample 
was analysed in triplicate and both positive and negative modes were used, producing 52.224 data 
points per sample per test. Once the data was obtained, the test data was exported and visualized 
using the Advanced Viewer software (version 4.2, Owlstone® Ltd, UK). A more detailed description 
and practical application of FAIMS has been reported previously (23).  
 
Urinary analysis 
Urine samples were analysed after a median storage period of six months, ranging between one and 
twelve months. Esfahani et al. observed no significant loss in VOCs within nine months of storage and 
proposed to analyse urine samples before twelve months (24). Before analysis, samples were first 
removed from the freezer to defrost at room temperature for a maximum of two hours. After defrosting, 
4.5 ml of urine sample was aliquoted into a 22 ml glass vial and placed in the ATLAS sample system 
(Owlstone®, UK). The system heats the urine samples to 38° C and controls the flow of dry clean air 
over the top of the sample and into the instrument. Room air was compressed (0.1 MPa) and cleaned 
before being blown over the sample at a flow rate 500 millilitre per minute and with a total flow into the 
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instrument of two litre per minute. Temperatures were pre-set at 38° C for the sample holder, 70° C for 
the lid and 100° C for the filter region. All urine samples were measured in triplicate. In between urine 
samples a sample of clean tap water was analysed in triplicate to ensure that the baseline response 
was returned. Glass vials were sanitized at the department of microbiology after each sample.  
 
Statistical analysis 
IBM SPSS statistics (version 23) was used for standard statistical analysis and “R” for urinary VOC 
data analysis. Continuous variables were expressed as median (range) or mean ± standard deviation 
and frequency percentages were calculated for dichotomous variables. Between-group comparisons 
were done with an independent sample t test or Mann-Whitney U test for continuous variables and a 
chi-square test or Fisher’s exact test (in case of small cell counts) for categorical variables. A p-value 
of <0.05 was considered statistically significant. Urinary VOCs of patients with anastomotic leakage 
were compared to control patients who had an uncomplicated postoperative course. Each sample 
resulted in 52.224 data points in a 2D matrix. Figure 1 shows visualized urinary VOC data, the 
samples are chosen closest to the mean of each group and therefore representative for the entire 
dataset. Data was processed using an existing pipeline (17, 23). A 2D wavelet transform (using 
Daubechies D4 wavelets) was utilized. Noise variables were identified by excluding the bottom 65% of 
variables from the analysis, ranked by standard deviation. The remaining variables were passed as 
input to a Random Forests classifier (25). Area under the receiver operating characteristics (AUROC), 
sensitivity, specificity and p-values were estimated using 10-fold cross validation, with confidence 
intervals (CI) computed using bias-corrected and accelerated (BCa) bootstrap intervals (26). A heat 
map, showing the number of times different variables in the data were used by the classifier is 
displayed in Figure 2, indicating which parts of the FAIMS data were important for classification. 
 
Ethical considerations 
The study protocol was approved by the Medical Ethical Review Committee (METc) of the VU 
University Medical Center (2015.272) and by the local institutional ethical review boards of the other 
four participating centres (Amphia Ziekenhuis Breda, Rode Kruis Ziekenhuis Beverwijk, Spaarne 
Gasthuis Haarlem and Dijklander Ziekenhuis Hoorn). All participants received both verbal and written 
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patient information, were capable of understanding the information and provided written informed 
consent.  
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Results 
Patient characteristics 
Urine samples of 22 patients with anastomotic leakage and 27 patients without anastomotic leakage 
following colorectal surgery were analysed. Twenty-six males and 23 females had a median age of 67 
years (39-87). Patients underwent surgery between March 2015 and December 2016. Procedures 
consisted of hemicolectomy (n=19, 38%), low anterior resection (n=16, 33%), sigmoid resection (n=6, 
12%), subtotal colectomy (n=5, 10%), closure of ostomy (n=2, 4%) and ileum resection (n=1, 2%). A 
minimally invasive approach was chosen in 40 patients (83%), four procedures (10%) were converted 
to open surgery, because of adhesions (n=2), adiposity (n=1) and lack of overview (n=1). Further 
patient characteristics are depicted in Table 1. In patients with anastomotic leakage significantly more 
lymph nodes were found in the resected specimens. Also, significantly more conversions from 
minimally invasive to open surgery were seen in patients with anastomotic leakage. No further 
statistically significant differences were seen between the groups. 
 
Anastomotic leakage 
Twenty-two patients with confirmed clinical anastomotic leakage were included. The median time to 
confirmation of leakage was three days (Interquartile Range (IQR): 1.75). No delay in suspicion of 
leakage, collection of urine samples and confirmation of diagnosis was observed. Clinical suspicion 
was confirmed by CT imaging (n=16, 73%) or laparotomy (n=6, 27%). All patients were treated by 
means of relaparotomy (n=19) or relaparoscopy (n=3) (grade C), during which surgical drains were 
placed (n=1), a diverting ileostomy was created to salvage the anastomosis (n=3), the anastomosis 
was recreated (n=6) or the anastomosis was taken down and an end colostomy or ileostomy was 
created (n=12).  
 
Biochemical examination 
Biochemical infectious markers were determined on the day urine samples were collected. Patients 
with a confirmed anastomotic leak had a mean level serum CRP of 271 (SD: 86 mg/l) compared to 
157 (SD: 96 mg/l) for control patients (p<0.001) and had an AUROC of 0.81 (95% CI: 0.68-0.95). 
The mean WBC was statistically increased in the presence of anastomotic leakage (p=0.048). The 
mean WBC count was 13.9 (SD: 7.0) at the time of confirmation of anastomotic leakage, compared to 
11 
 
10.5 (SD: 3.5) for control patients. WBC had an AUROC of 0.66 (95% CI 0.49-0.84). The clinical 
course of patients is summarized in Table 2. 
 
Volatile organic compound analysis 
Analysis showed that urinary VOC profiles of patients with anastomotic leakage could be discriminated 
from uneventful control patients. The results are shown in a box plot of probability (Figure 3). An 
AUROC of 0.91 (95% CI: 0.81-1.00, p<0.001) was achieved, and the ROC curve is displayed in Figure 
4. At the optimum cut-off point a corresponding sensitivity of 0.86 (95% CI: 0.65-0.96) and specificity 
of 0.93 (95% CI: 0.75-1.00) was computed. 
 
Combined markers 
A combined predictive performance for serum CRP and urinary VOC profiles was computed. To allow 
for a fair comparison, CRP AUROC was cross-validated on the same folds as the VOC profiles. 
However, serum CRP was not measured for all patients in the control group leading to an 
underestimation because less data was available in each fold for selecting the optimum classification 
threshold. This led to an AUROC of 0.75 (95% CI 0.60-0.91) for CRP alone, which compares to an 
AUC of 0.92 (95% CI: 0.83-1.00) for VOC profiles alone when restricted to patients with CRP data. 
Combining CRP and VOCs an AUROC of 0.95 (95% CI: 0.89-1.00) was achieved. This improvement 
of 0.03 (95% CI: -0.028-0.13) was not significant at a 95% confidence level.  
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Discussion 
In this study, urine samples of patients with colorectal anastomotic leakage were compared to urine 
samples of uneventful control patients. Analysis of FAIMS data showed that urinary VOC patterns 
could be used to discriminate between groups with a superior accuracy compared to serum CRP. 
These results suggest that urine analysis by means of FAIMS has potential as a non-invasive tool to 
detect postoperative anastomotic leakage. 
 
This study is the first to our knowledge to investigate urinary VOCs, or VOCs in any bodily excrement, 
to detect colorectal anastomotic leakage. Previous research showed that urinary VOC patterns could 
predict anastomotic leakage correctly at an early stage following pancreatic surgery (AUROC 0.85), 
but not after oesophageal surgery (AUROC: 0.51). Present results suggest a superior accuracy of 
urinary VOC analysis following colorectal surgery compared to pancreatic surgery, however it must be 
noted that this study was designed as a cross-sectional study while in the pancreatic surgery study a 
longitudinal design was applied (18). 
 
In previous decades, several specific biomarkers for infectious complications following colorectal 
surgery have been proposed (27, 28). Among surgeons, serum CRP level is the best known and is 
frequently determined biomarker during the postoperative period. Recent studies found that patients 
who developed anastomotic leakage could be discriminated from control patients with only modest 
accuracy following colorectal surgery (postoperative day five, AUROC: 0.79) (12). An increased 
accuracy was observed for infectious complications following rectal surgery (postoperative day four, 
AUROC: 0.88) (10). Next to CRP, procalcitonin has been proposed as a biomarker for severe 
anastomotic leakage following colon surgery. At the optimal cut-off point on postoperative day five an 
AUROC of 0.74 was found (12).  
 
Other urinary biomarkers for colorectal anastomotic leakage have been proposed. Dusek et al. (29) 
evaluated the use of neopterin, kynurenine and tryptophan as predictors of anastomotic leakage 
following rectal surgery. Results show that high preoperative and postoperative levels of urinary 
neopterin were seen in patients with colorectal anastomotic leakage. It was suggested that urinary 
neopterin could be a useful marker for leakage.  
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The apparently high specificity of urinary VOCs compared to other markers underlines the potential of 
this novel method to serve as a complementary routine non-invasive biomarker in the diagnosis of 
anastomotic leakage. It must be noted that in the present study urinary analysis was performed in 
patients with a high suspicion of anastomotic leakage and observed leaks were early and severe 
(median postoperative day 3 and requiring surgical intervention). Hence, extrapolating the current data 
to diagnostic value of VOC analysis in the detection of subtle or delayed anastomotic leakage must be 
done cautiously. Neither does it elucidate the place of urinary VOC analysis in screening for leakage, 
since urine samples were collected once anastomotic leakage was already highly suspected. Future 
longitudinal studies should preferably collect urine on certain pre- and postoperative time points to 
determine the ability of urinary VOCs to predict anastomotic leakage. Obviously, upon externai 
validation of presented results in a longitudinal study, implementation of VOC analysis could possibly 
facilitate earlier recognition of anastomotic leakage and has the potential to avert surgical 
management and allow treatment in a less invasive manner.  
 
As VOC analysis by FAIMS has yet to make it into clinical practice, only specialized research facilities 
have access to this technology. Even though actual sampling is quick and inexpensive, methodologies 
utilized in medical studies are costly and time-consuming. Samples are frozen and stored for batch 
sampling followed by extensive data analysis, which is not feasible in clinical practice. It appears that 
freezing and storage of urine samples does not result in a significant loss of VOCs, however real-time 
sampling of unfrozen urine samples requires further investigation. Likely future developments are 
necessary for this technique to be of clinical value, instant sample analysis is a prerequisite and data-
processing should preferably be incorporated in the instrument itself (23).  
 
Apart from urine, faeces and exhaled breath have also been proposed as biological media to detect 
human VOCs. Metabolites of intestinal pathophysiological processes are primarily discharged in 
faeces. Faecal VOCs have shown to be highly accurate biomarkers for gastrointestinal diseases (30-
32). Application in colorectal surgery patients however is limited due to temporary impairment of bowel 
mobility in postoperative patients. Collection of urine is “patient friendly” and can be provided on 
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demand. Urine collection was preferred over exhaled breath, due to high costs and logistical 
challenges of collection, storage and analysis of exhaled breath.  
 
In this study FAIMS was used. Although gas chromatography combined with mass spectrometry (GC-
MS) is considered the gold standard of VOC analysis, FAIMS has much higher sensitivity, requires 
less infrastructure and has a shorter analysis time. This may make it more realistic as a routine 
diagnostic tool. However, GC-MS allows for identification of individual VOCs based on their 
physiochemical properties. In the near future, GC-MS will be used to identify individual VOCs to 
further understand the pathophysiology behind colorectal anastomotic leakage.  
 
A limitation of this pilot study is its cross-sectional design, which resulted in a variable timing of urine 
collection in the anastomotic leakage cohort and the inability to assess the potential influence of other 
factors. However, this design was favoured over a longitudinal design, since the incidence of 
anastomotic leakage following colorectal surgery is low and therefore a cross-sectional approach is 
the most feasible first step to identify specific VOC markers without needing a large number of 
patients. Secondly, our pilot design resulted in a small sample size and inability to match groups on 
specific baseline characteristics. Future studies should preferably be performed in a multicentre, 
prospective, longitudinal design, and collect urine on certain pre- and postoperative time points to 
allow for detailed assessment of the intra-individual course of specific urinary VOC patterns and to 
investigate its ability to predict anastomotic leakage. 
 
In conclusion, urinary VOC analysis by FAIMS allowed for discrimination between patients with 
anastomotic leakage and uneventful postoperative patients after colorectal surgery. A superior 
accuracy compared to serum CRP was observed, underlining its potential as a non-invasive biomarker 
for the detection of colorectal anastomotic leakage. 
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Figure 1. Visualized urinary VOC data generated using FAIMS, which measures ion counts by altering 
compensation voltages (+6 to -6 V in 512 steps) and magnitude of electric field (the dispersion field, 0 
to 100% in 51 steps) to produce 52.224 data points per sample per test. This figure shows the 
negative/positive ion counts for an patient with anastomotic leakage and a control patient. The specific 
plumes indicate the presence of specific VOCs in the urine sample. VOCs: volatile organic 
compounds, FAIMS: field asymmetric ion mobility spectrometry. 
 
Figure 2. Heat map of the number of times different variables in the data were used by the classifier, 
indicating which parts of the FAIMS data were important for classification. The grey background shows 
all the plumes in the data set. The red overlay highlights which variables were used by the classifier, 
brightness indicated frequency. FAIMS: field asymmetric ion mobility spectrometry. 
 
Figure 3. Analysis of urinary VOCs resulted in a predicted probability of anastomotic leakage for each 
sample. This figure shows the predicted probability for both groups (anastomotic leakage and control 
patients). AL: anastomotic leakage VOCs: volatile organic compounds. 
 
Figure 4. ROC-curve with 95% confidence interval for diagnosis of anastomotic leakage compared to 
control patients. AUC: 0.91 (95% CI: 0.81-1.00, p<0.001). ROC: Receiver operating characteristics, 
AUC: area under the curve. 
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Characteristic AL (n = 22) Controls (n = 27) P-value 
Female gender 9 (41) 14 (52) 0.318 
Age (year) 67.3 ± 11.1 67.0 ± 11.1 0.930 
BMI (kg/m2) 27.1 ± 3.7 27.5 ± 8.0 0.849 
ASA 2 (1 – 3) 2 (1 – 3) 0.705 
Comorbidities    
Hypertension  11 (50) 14 (52) 0.897 
Heart failure 2 (9) 4 (15) 0.438 
COPD 4 (18) 4 (15) 0.618 
Diabetes Mellitus 4 (18) 8 (30) 0.279 
Chronic kidney disease 2 (9) 1 (4) 0.422 
Indication for surgery   0.231 
Cancer 19 (86) 26 (96)  
Diverticulitis 3 (14) 1 (4)  
Tumour pathology    
T-stadium 3 (0 – 4) 2 (0 – 4) 0.642 
N-stadium 0 (0 – 2) 0 (0 – 2) 0.909 
Minimally invasive surgery 17 (77) 22 (81) 0.635 
Conversion 4 (24) 0 (0) 0.029* 
Type of surgery   0.888 
Hemicolectomy 8 (36) 11 (41)  
Sigmoid resection 3 (14) 3 (11)  
Low anterior resection 6 (27) 10 (37)  
Subtotal colectomy 3 (14) 2 (7)  
Small intestine 1 (5) 0 (0)  
Ostomy closure 1 (5) 1 (4)  
Lymph nodes resected 19 (9 – 45) 13 (2 – 40) 0.020* 
 
Data are n (%), mean ± standard deviation and median (range) 
Anastomotic leakage (AL), Body mass index (BMI), American Society of Anaesthesiologists (ASA), Chronic 
obstructive pulmonary disease (COPD). * Significant  
Table 1. Summary of demographic and clinical characteristics 
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Parameter AL (n = 22) Controls (n = 27) P-value 
Leakage grade (ISREC)    
Grade A 0 (0) -  
Grade B 0 (0) -  
Grade C 22 (100) -  
Sample collection (POD) 3 (1 – 10) 3  
Storage time (months) 5 (1 – 12)  6 (1 – 12) 0.571 
Serum CRP 271 ± 86 157 ± 96 <0.001* 
WBC 13.9 ± 7.0 10.5 ± 3.5 0.048* 
Other complications    
Pneumonia 1 (5) 1 (4) 0.702 
Gastroparesis 1 (5) 1 (4) 0.702 
Atrial fibrillation 2 (9) 1 (4) 0.422 
Ileus 2 (9) 1 (4) 0.422 
Wound infection 2 (9) 0 (0) 0.196 
Urinary retention 3 (14) 0 (0) 0.084 
Respiratory insufficiency 2 (9) 0 (0) 0.196 
Hospital stay (days) 24 (11 – 67) 5 (3 – 34) <0.001* 
ICU stay (days) 2 (0 – 40) 0 (0 – 1) 0.035* 
30-day mortality 0 (0) 0 (0)  
 
Data are n (%), mean ± standard deviation and median (range) 
Anastomotic leakage (AL), International Study Group of Rectal Cancer (ISREC), Postoperative day (POD), C-
reactive protein (CRP), White blood cell count (WBC), Intensive care unit (ICU). * Significant  
Table 2. Summary of clinical course 
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Figure 1. Visualized urinary VOC data generated using FAIMS, which measures ion counts by altering 
compensation voltages (+6 to -6 V in 512 steps) and magnitude of electric field (the dispersion field, 0 
to 100% in 51 steps) to produce 52.224 data points per sample per test. This figure shows the 
negative/positive ion counts for an patient with anastomotic leakage and a control patient. The specific 
plumes indicate the presence of specific VOCs in the urine sample. VOCs: volatile organic 
compounds, FAIMS: field asymmetric ion mobility spectrometry. 
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Figure 2. Heat map of the number of times different variables in the data were used by the classifier, 
indicating which parts of the FAIMS data were important for classification. The grey background shows 
all the plumes in the data set. The red overlay highlights which variables were used by the classifier, 
brightness indicated frequency. FAIMS: field asymmetric ion mobility spectrometry.  
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Figure 3. Analysis of urinary VOCs resulted in a predicted probability of anastomotic leakage for each 
sample. This figure shows the predicted probability for both groups (anastomotic leakage and control 
patients). AL: anastomotic leakage VOCs: volatile organic compounds. 
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Figure 4. ROC-curve with 95% confidence interval for diagnosis of anastomotic leakage compared to 
control patients. AUC: 0.91 (95% CI: 0.81-1.00, p<0.001). ROC: Receiver operating characteristics, 
AUC: area under the curve. 
